The introduction of multidrug combination chemotherapy has significantly advanced the long-term survival prospects for osteosarcoma (OS) patients over the past decades. However. the escalating prevalence of chemoresistance has emerged as a substantial impediment to further advancements. necessitating the formulation of innovative strategies. https://megavitamines.shop/product-category/vision-care/